Answers are grounded in this paper and cite their sources.
Observational analysis demonstrates clinical outcomes linked to antidepressant exposure in lung cancer receiving immunotherapy, suggesting potential medication interactions.
Lung cancer is a leading cause of cancer mortality. Immune checkpoint inhibitors targeting programmed cell death protein 1 (PD-1) or programmed death-ligand 1 (PD-L1) improve outcomes, but associations between antidepressant exposure and immunotherapy effectiveness remain uncertain.
No takes yet. Share an insight, caveat, or question.
M. et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: